NEW ORLEANS -- In an interview at the Society of Nuclear Medicine and Molecular Imaging annual meeting, Phillip Kuo, MD, PhD, of the City of Hope in Duarte, CA, discussed new appropriate use criteria for amyloid and tau PET imaging in Alzheimer’s disease patients.
Video from SNMMI: Phillip Kuo on new Alzheimer’s disease imaging guidelines
Latest in Molecular Imaging
SNMMI notes pros and cons in CMS final 2026 OPPS rule
November 26, 2025
ConcertAI launches new reimbursement tool
November 21, 2025
UCLA to launch department of nuclear medicine and theranostics
November 19, 2025





















